FD1024 is a PIM inhibitor (IC50s against PIM1, PIM2, and PIM3 are 1.96, 38.9, and 4.17 nM, respectively); it is used in the research of acute myeloid leukemia (AML); it exhibits potent anti-proliferative activity against tested AML cell lines, with IC50 values of 0.16 μM, 0.12 μM, 1.05 μM, and 1.39 μM against EOL-1, MV-4-11, KG-1, and MOLM-16 cells, respectively; it also demonstrates anti-tumor efficacy in mice.